Patrick Machado, 10% Owner at Urovant Sciences Ltd. (UROV), bought 27,662 shares at $7.59 ($218K) on 2019-06-04, disclosed to the SEC on 2019-06-06.
Open-market purchase of $218k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.59 | 7,500 | $57K | 26.1% |
| 2 | $8.02 | 6,540 | $52K | 24.0% |
| 3 | $8.02 | 6,540 | $52K | 24.0% |
| 4 | $8.00 | 7,082 | $57K | 25.9% |
| Total | $7.90 avg | 27,662 | $218K | 100% |
| Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |